Alto Neuroscience, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-33.4M | $-33.9M | $470.0K | $2.9M |
| FY2024 | $-47.4M | $-49.5M | $2.1M | $7.6M |
| FY2025 | $-51.8M | $-51.8M | $24.0K | $8.1M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-33.4M | $-33.9M | $470.0K | $2.9M |
| FY2024 | $-47.4M | $-49.5M | $2.1M | $7.6M |
| FY2025 | $-51.8M | $-51.8M | $24.0K | $8.1M |